Eisai Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Eisai Company Limited with three other
companies in this sector in JAPAN :
Ono Pharmaceutical Co Ltd
sales of 292.42 billion Japanese Yen [US$2.77 billion]
of which 70%
was Products & Goods),
Daiichi Sankyo Company Limited
(981.79 billion Japanese Yen [US$9.30 billion]
of which 93%
was Prescription drugs), and
Shionogi & Co Ltd
(333.37 billion Japanese Yen [US$3.16 billion]
of which 100%
was Prescription Drugs related business).
Eisai Company Limited reported sales of ¥695.62 billion (US$6.59 billion)
March of 2020.
increase of 8.2%
versus 2019, when the company's sales were ¥642.83 billion.
This was the third consecutive year of growth at Eisai Company Limited.
Sales of Other Business saw an increase
that was more than double the company's growth rate: sales were up
49.6% in 2020, from
¥79.09 billion to ¥118.36 billion.